Although the SARS-CoV-2 virus that causes COVID-19 appears to be a covert, unstoppable intruder, that doesn’t mean that we can’t fortify our defenses to try and stop it in its tracks.
Adopting healthy changes in diet and lifestyle can also reduce your risk of the comorbidities associated with severe COVID-19: [1] [2] [3] [4] [5] [6] [7] [8]
Here are some optimal takeaways for improving your immune defenses against COVID-19:
Remember that optimal lab ranges are narrower than standard lab ranges and may give earlier clues to imbalance or deficiency.
A healthy dietary pattern modeled on the Mediterranean diet or DASH diet can help reduce the risk of chronic metabolic diseases and in turn, reduce the risk of severe COVID-19:
Other factors should be considered in the fight to prevent and treat COVID-19 including:
Finally, be aware that a variety of adverse outcomes can persist even after perceived recovery from COVID-19 and can include:
[1] Ejaz, Hasan et al. “COVID-19 and comorbidities: Deleterious impact on infected patients.” Journal of infection and public health vol. 13,12 (2020): 1833-1839. doi:10.1016/j.jiph.2020.07.014
[2] Gallo Marin, Benjamin et al. “Predictors of COVID-19 severity: A literature review.” Reviews in medical virology, e2146. 30 Jul. 2020, doi:10.1002/rmv.2146
[3] Richardson, David P, and Julie A Lovegrove. “Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective.” The British journal of nutrition, 1-7. 20 Aug. 2020, doi:10.1017/S000711452000330X
[4] Nandy, Kunal et al. “Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.” Diabetes & metabolic syndrome vol. 14,5 (2020): 1017-1025. doi:10.1016/j.dsx.2020.06.064
[5] Albitar, Orwa et al. “Risk factors for mortality among COVID-19 patients.” Diabetes research and clinical practice vol. 166 (2020): 108293. doi:10.1016/j.diabres.2020.108293
[6] Zheng, Zhaohai et al. “Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.” The Journal of infection vol. 81,2 (2020): e16-e25. doi:10.1016/j.jinf.2020.04.021
[7] Hernández-Galdamez, Diego Rolando et al. “Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.” Archives of medical research vol. 51,7 (2020): 683-689. doi:10.1016/j.arcmed.2020.07.003
[8] Baradaran, Ashkan et al. “Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis.” The archives of bone and joint surgery vol. 8,Suppl 1 (2020): 247-255. doi:10.22038/abjs.2020.47754.2346